RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma (NASDAQ:RDHL) investors are sitting on a loss of 89% if they invested five years ago

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see...

• 
  Shareholders in Werewolf Therapeutics (NASDAQ:HOWL) are in the red if they invested a year ago

  Simply Wall St.
• 
  Caspian Sunrise (LON:CASP) shareholders have endured a 66% loss from investing in the stock three years ago

  Simply Wall St.

RedHill Announces New H. pylori and COVID-19 Data Publication and Presentations at Leading Upcoming Scientific Conferences

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announced the upcoming presentation of new Talicia® H. pylori eradication data as well as publication and presentation of data from the opaganib and RHB-107 (upamostat) late clinical-stage COVID-19 programs at important medical congresses in July and August, 2022.

Raleigh drugmaker slashes workforce as biotech downturn deepens

The drugmaker is cutting one-third of its U.S. commercial workforce as part of a plan to save $50 million. The move comes as the biotech industry sees cuts across the board as the highs of the pandemic fade away.